Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Matesanz
E Coll

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDRZhicai Wu, Mark E Fraley, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDRMark T Bilodeau, April M Cunningham, Timothy J Koester, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinaseMark T Bilodeau, Leonard D Rodman, Georgia B McGaughey, et al.
Langenbeck'S Archives of Surgery|April 30, 2013
Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?N Muñoz Pérez, J M Villar del Moral, M A Muros Fuentes, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokineticsMark E Fraley, Robert S Rubino, William F Hoffman, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitorsMark E Fraley, Kenneth L Arrington, Scott R Hambaugh, et al.
Medicina Intensiva|November 20, 2019
[Intensive care to facilitate organ donation. ONT-SEMICYUC recommendations]D Escudero Augusto, F Martínez Soba, B de la Calle, et al.
Anaesthesia|June 5, 2015
Intensive care practices in brain death diagnosis and organ donationD Escudero, M O Valentín, J L Escalante, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2012
Continuously evaluating performance in deceased donation: the Spanish quality assurance programG de la Rosa, B Domínguez-Gil, R Matesanz, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDRZhicai Wu, Mark E Fraley, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDRMark T Bilodeau, April M Cunningham, Timothy J Koester, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinaseMark T Bilodeau, Leonard D Rodman, Georgia B McGaughey, et al.
Langenbeck'S Archives of Surgery|April 30, 2013
Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?N Muñoz Pérez, J M Villar del Moral, M A Muros Fuentes, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokineticsMark E Fraley, Robert S Rubino, William F Hoffman, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitorsMark E Fraley, Kenneth L Arrington, Scott R Hambaugh, et al.
Medicina Intensiva|November 20, 2019
[Intensive care to facilitate organ donation. ONT-SEMICYUC recommendations]D Escudero Augusto, F Martínez Soba, B de la Calle, et al.
Anaesthesia|June 5, 2015
Intensive care practices in brain death diagnosis and organ donationD Escudero, M O Valentín, J L Escalante, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2012
Continuously evaluating performance in deceased donation: the Spanish quality assurance programG de la Rosa, B Domínguez-Gil, R Matesanz, et al.
Pageof 25